Allergy & Asthma Network Applauds Congressional Funding for the National Asthma Control Program
Allergy & Asthma Network applauds Congress for approving funding for the CDC’s National Asthma Control Program.
Allergy & Asthma Network applauds Congress for approving funding for the CDC’s National Asthma Control Program.
You are invited to attend the 29th annual Allergy & Asthma Day Capitol Hill (AADCH) advocacy day on Wednesday, May 6 in Washington, DC. Join fellow advocates to meet with members of Congress and their staff, and lend your voice on behalf of millions of people living with asthma, allergies and related conditions in the…
By Nissa Shaffi, Director of Advocacy, Allergy & Asthma Network In January 2026, the U.S. Department of Health and Human Services (HHS) and the U.S. Centers for Disease Control and Prevention (CDC) announced major changes to the childhood immunization schedule, reducing the number of recommended vaccines from 17 to 11. Current vaccine recommendations CDC now…
This webinar was recorded on March 18, 2026 Despite advances in treatment, many patients with asthma remain uncontrolled, experiencing frequent exacerbations, persistent symptoms, and reduced quality of life. Managing severe and uncontrolled asthma requires a personalized, evidence-based approach that accounts for disease heterogeneity, comorbidities, and patient-specific factors. Join us for this CME-certified webinar as Dr….
Allergy & Asthma Network is concerned about the impact on patients as the pandemic-era Affordable Care Act premium subsidies are set to expire.
Updated USDA Dietary Guidelines recommend introduction of potential food allergens to children in the first year of life.
This Webinar was recorded on March 12, 2026 Do you experience ongoing sinus symptoms such as nasal congestion, facial pressure, sinus pain, or loss of smell? If these symptoms don’t improve, they may be caused by nasal polyps or chronic rhinosinusitis with nasal polyps (CRSwNP), a chronic inflammatory sinus condition that can significantly affect quality…
New program empowers patients and caregivers to influence healthcare policy and drive meaningful change. FAIRFAX, VA, JAN. 15, 2026 – Allergy & Asthma Network is proud to announce the launch of the Patient Advocacy Leadership Initiative (PALI). This multifaceted program is designed to build a nationwide network of informed, empowered patient advocates who are ready…
This webinar was recorded on February 19, 2026 Depression and anxiety are common in patients with asthma and are frequently overlooked contributors to poor disease control, reduced treatment adherence, and diminished quality of life. Emerging evidence highlights the complex interactions between behavioral health, immune function, and respiratory disease. In this engaging webinar, we will delve…
Explore 40 years of advancements in allergy and asthma care, celebrating achievements and looking ahead.
Discover essential advocacy types and strategies to drive meaningful change. Learn how to effectively make your voice heard and inspire action.
This webinar was recorded on January 20th, 2026 Respiratory Syncytial Virus (RSV) remains a significant source of concern across vulnerable populations, including infants, older adults, and patients with chronic respiratory or immune conditions. As prevention and treatment options evolve, clinicians benefit from clear, up-to-date guidance that supports effective risk evaluation, patient counseling, and proactive seasonal…
End of content
End of content

10304 Eaton Place, Suite 100
Fairfax, VA 22030
Phone: 800-878-4403
Join Our Newsletter
Keep up with the latest news from AAN, right in your inbox! Choose from our eNewsletter, Research or EXHALE newsletters.
🔐 We do not share or sell your information.